These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 6299185)

  • 21. Elimination kinetics of ceftizoxime in humans with and without renal insufficiency.
    Ohkawa M; Okasho A; Sugata T; Kuroda K
    Antimicrob Agents Chemother; 1982 Aug; 22(2):308-11. PubMed ID: 6100425
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Fundamental and clinical studies of ceftizoxime in obstetrical and gynecological field].
    Hayasaki M; Iwasa S; Kondo H; Itoh K; Noda K
    Jpn J Antibiot; 1982 Sep; 35(9):2252-76. PubMed ID: 6292542
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ceftizoxime. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.
    Richards DM; Heel RC
    Drugs; 1985 Apr; 29(4):281-329. PubMed ID: 3888599
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ceftizoxime elimination kinetics in continuous ambulatory peritoneal dialysis.
    Gross ML; Somani P; Ribner BS; Raeader R; Freimer EH; Higgins JT
    Clin Pharmacol Ther; 1983 Nov; 34(5):673-80. PubMed ID: 6313276
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacokinetics of intravenous ceftizoxime in patients on continuous ambulatory peritoneal dialysis.
    Johnson CA; Zimmerman SW; Bayer W; Craig WA
    Clin Nephrol; 1985 Mar; 23(3):120-4. PubMed ID: 3857136
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Laboratory and clinical studies on ceftizoxime in the field of pediatrics (author's transl)].
    Toyonaga Y; Kurosu Y; Sugita M; Kawamura G; Okuyama M; Yoshino N; Hori M; Takahashi T
    Jpn J Antibiot; 1982 Jan; 35(1):9-32. PubMed ID: 6279916
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Ceftizoxime concentration in blood, muscle, and kidney tissue].
    Westenfelder M; Daschner F; Frankenschmidt A
    Infection; 1984; 12(1):17-9. PubMed ID: 6323319
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacokinetics of ceftizoxime in patients undergoing hemodialysis.
    Shah PM; Knobloch M; Haag R; Kühnle HF
    Methods Find Exp Clin Pharmacol; 1982; 4(3):185-8. PubMed ID: 6289027
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impaired clearance of ceftizoxime and cefotaxime after orthotopic liver transplantation.
    Burckart GJ; Ptachcinski RJ; Jones DH; Howrie DL; Venkataramanan R; Starzl TE
    Antimicrob Agents Chemother; 1987 Feb; 31(2):323-4. PubMed ID: 3551835
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Pharmacokinetics of ceftizoxime with and without probenecid].
    Adam D; Timmler R
    Arzneimittelforschung; 1982; 32(4):416-9. PubMed ID: 6285937
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ciprofloxacin, azlocillin, ceftizoxime and amikacin alone and in combination against gram-negative bacilli in an infected chamber model.
    Bamberger DM; Peterson LR; Gerding DN; Moody JA; Fasching CE
    J Antimicrob Chemother; 1986 Jul; 18(1):51-63. PubMed ID: 3093445
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Treatment of ciprofloxacin- and ceftizoxime-induced resistant gram-negative bacilli.
    Fasching CE; Gerding DN; Peterson LR
    Am J Med; 1987 Apr; 82(4A):80-6. PubMed ID: 3472465
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Penetration of N-formimidoyl thienamycin into extravascular fluids in rabbits.
    Olay T; Vicente MV; Rodríguez A
    Chemotherapy; 1986; 32(5):404-7. PubMed ID: 3463447
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Microcalorimetric study of the kinetics of the antibacterial effect of third generation cephalosporins in an in vitro dynamic system].
    Nazarov AD; Firsov AA; Chernykh VM
    Antibiot Khimioter; 1991 Sep; 36(9):16-9. PubMed ID: 1781702
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Biliary excretion of ceftizoxime in humans.
    Brogard JM; Arnaud JP; Timmler R
    Chemotherapy; 1984; 30(4):221-6. PubMed ID: 6086245
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacokinetics of tissue penetration of antibiotics.
    Bergan T
    Rev Infect Dis; 1981; 3(1):45-66. PubMed ID: 7013000
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ceftizoxime: a beta-lactamase-stable, broad-spectrum cephalosporin. Pharmacokinetics, adverse effects and clinical use.
    Neu HC
    Pharmacotherapy; 1984; 4(2):47-60. PubMed ID: 6326062
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Ceftizoxime and its place in the context of modern cephalosporins].
    Nitti V
    Clin Ter; 1986 May; 117(3):233-60. PubMed ID: 3524975
    [No Abstract]   [Full Text] [Related]  

  • 39. Comparative pharmacokinetics of ceftizoxime and other third-generation cephalosporins in humans.
    Quintiliani R; Nightingale CH
    J Antimicrob Chemother; 1982 Nov; 10 Suppl C():99-104. PubMed ID: 6296035
    [No Abstract]   [Full Text] [Related]  

  • 40. Pharmacokinetics of ceftizoxime.
    Cutler RE; Blair AD; Burgess ED; Parks D
    J Antimicrob Chemother; 1982 Nov; 10 Suppl C():91-7. PubMed ID: 6296034
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.